An Mse I RFLP in the human CTLA4 promotor

被引:136
作者
Deichmann, K
Heinzmann, A
Bruggenolte, E
Forster, J
Kuehr, J
机构
[1] University Children's Hospital, University of Freiburg, D 79106 Freiburg
关键词
D O I
10.1006/bbrc.1996.1256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present a PCR-based Mse I restriction fragment length polymorphism (RFLP) in the promotor of the human CTLA4 gene at position -318 relative to the ATG start codon. In a random caucasian population including 239 individuals the allele frequency of the polymorphism was 13.4%, with a calculated heterozygosity rate of 23.2% and an observed one of 25.1%. CTLA4 and CD28 are two genes in close proximity on the long arm of chromosome 2. Both of them influence T-cell activity in an antigen-independent way. They represent candidate genes for several immunological disorders. Recently association between the CTLA4 gene and Graves' disease has been shown. The Mse I RFLP in the CTLA4 promotor might serve as a useful tool for further association studies. (C) 1996 Academic Press, Inc.
引用
收藏
页码:817 / 818
页数:2
相关论文
共 10 条
[1]   THE YIN AND YANG OF T-CELL COSTIMULATION [J].
ALLISON, JP ;
KRUMMEL, MF .
SCIENCE, 1995, 270 (5238) :932-933
[2]   MOLECULAR LINKAGE OF THE HUMAN CTLA4 AND CD28 IG-SUPERFAMILY GENES IN YEAST ARTIFICIAL CHROMOSOMES [J].
BUONAVISTA, N ;
BALZANO, C ;
PONTAROTTI, P ;
LEPASLIER, D ;
GOLSTEIN, P .
GENOMICS, 1992, 13 (03) :856-861
[3]  
DARIAVACH P, 1989, CYTOGENET CELL GENET, V51, P983
[4]  
HARPER K, 1991, J IMMUNOL, V147, P1037
[5]   DETECTION OF POINT MUTATIONS IN THE ANDROGEN RECEPTOR GENE USING NONISOTOPIC SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS [J].
HIORT, O ;
WODTKE, A ;
STRUVE, D ;
ZOLLNER, A ;
SINNECKER, GHG ;
ALBERS, N ;
BEYE, M ;
BEYER, P ;
BIRR, C ;
BLUNCK, W ;
BRACK, C ;
BRAMSWIG, J ;
DORR, HG ;
GAL, A ;
HECKER, W ;
HEIDEMANN, P ;
HEINRICH, U ;
HEISE, HR ;
HESSE, V ;
HINKEL, M ;
HOEPFFNER, W ;
HOLDER, M ;
KEIM, L ;
KLASEN, M ;
KORSCH, E ;
KRUGER, G ;
LANDENDORFER, W ;
MIX, M ;
MORLOT, M ;
MUHLENBERG, R ;
OTTEN, A ;
PARTSCH, CJ ;
PELZ, L ;
VONPETRYKOWSKI, W ;
RABL, W ;
REICH, H ;
SCHENK, B ;
SCHNABEL, D ;
SIPPELL, W .
HUMAN MOLECULAR GENETICS, 1994, 3 (07) :1163-1166
[6]  
LAFAGEPOCHITALOFF M, 1990, IMMUNOGENETICS, V31, P198
[7]  
ORITA M, 1989, GENOMICS, V5, P156
[8]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[9]   LYMPHOPROLIFERATIVE DISORDERS WITH EARLY LETHALITY IN MICE DEFICIENT IN CTLA-4 [J].
WATERHOUSE, P ;
PENNINGER, JM ;
TIMMS, E ;
WAKEHAM, A ;
SHAHINIAN, A ;
LEE, KP ;
THOMPSON, CB ;
GRIESSER, H ;
MAK, TW .
SCIENCE, 1995, 270 (5238) :985-988
[10]   CTLA-4 GENE POLYMORPHISM ASSOCIATED WITH GRAVES-DISEASE IN A CAUCASIAN POPULATION [J].
YANAGAWA, T ;
HIDAKA, Y ;
GUIMARAES, V ;
SOLIMAN, M ;
DEGROOT, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) :41-45